Symbol: |
SLC35C2
|
Description: |
solute carrier family 35, member C2 [Source:HGNC Symbol;Acc:17117]
|
Location: |
Chr20:44978167-44993043[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:196
Gene |
Compound |
Gen_sig |
Exp_pattern |
SLC35C2 |
Indeno[1,2-c]isoquinoline-5,11-dione, 6-methyl- 5-(methylsulfonyloxy)-5,6,6a,11a-tetrahydro- 2,3,8-trimethoxy-, cis- |
0.02 |
Up |
SLC35C2 |
NSC 49692 |
0.011 |
Up |
SLC35C2 |
NSC 49713 |
0.046 |
Up |
SLC35C2 |
NSC 49789 |
0.025 |
Up |
SLC35C2 |
C.I. 37559 |
0.026 |
Up |
SLC35C2 |
NSC 56614 |
0.035 |
Down |
SLC35C2 |
RAPAMYCIN PRODRUG |
0.028 |
Up |
SLC35C2 |
Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt |
0.039 |
Up |
SLC35C2 |
Benzoic acid, 2-hydroxy-, (2,6-pyridinediyldiethylidyne)dihydrazide, manganese chloride complex |
0.001 |
Up |
SLC35C2 |
6H-Pyrido[4,3-b]carbazolium, 9-hydroxy-2,5,11-trimethyl-, (SP-4-1)-tetrachloroplatinate(2-) (2:1) |
0.027 |
Up |
SLC35C2 |
1-Naphthalenecarboxamide, N,N'-1,8-(octanediyl)bis- |
0.011 |
Up |
SLC35C2 |
cis-Dichlorobis(4-methoxyphenethylamine)platinum(II) |
0.026 |
Down |
SLC35C2 |
Imidazo[2,1-b]thiazole-5-carboxamide, N-[(4-chlorophenyl)-aminocarbonyl]- |
0.005 |
Up |
SLC35C2 |
4,8-Ethenobenzo[1,2-c:4,5-c']dipyrrole-1,3,5,7-tetrone, 2,6-bis(3-cyanophenyl)-1,2,3,3a,4,4a,5,6,7,7a,8,8a- dodecahydro- |
0.024 |
Up |
SLC35C2 |
3,8,13,18-Pentaazapentacosane pentahydrochloride |
0.033 |
Down |
Expression pattern: Sensitivity / Resistance
Total:14 Current:3
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:13
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:55
Total:4 Current:1
[First] [Prev]  Next Last 
|